The Utility of Urine-Based Sampling for Cervical Cancer Screening in Low-Resource Settings

Sasidharanpillai Sabeena, Santhosh Kuriakose, Damodaran Binesh, Jazeel Abdulmajeed, Giselle Dsouza, Amrutha Ramachandran, Bindu Vijaykumar, Sushama Aswathyraj, Santhosha Devadiga, Nagaraja Ravishankar, Govindakarnavar Arunkumar

Research output: Contribution to journalArticle

Abstract

Background: WHO has recommended Visual Inspection with Acetic acid (VIA) or Human Papillomavirus (HPV) DNA testing if feasible, for cervical cancer screening in low income countries. However, the number of women undergoing screening is very low as a result of limited information, inadequate infrastructure and invasive nature of sampling. Methods: A cross sectional study was carried out comparing HPV DNA detection by Polymerase Chain Reaction (PCR) in paired cervical and urine samples procured from histologically confirmed cervical cancer cases. Results: Amongst the samples collected from 114 cervical cancer cases, HPV DNA was tested positive in cervical samples of 89 (78.1%) and urine samples of 55 (48.2%) patients. The agreement between the two sampling methods was 66.7% and the kappa value was 0.35 indicating a fair agreement. The sensitivity of HPV detection using urine samples was 59.6% (95% confidence interval 49.16%-69.15%) and the specificity was 92% (95% confidence interval 75.0%-97.8%). Conclusion: Even though not acceptable as an HPV DNA screening tool due to low sensitivity, the urine sampling method is inexpensive and more socially acceptable for large epidemiological surveys in developing countries to estimate the burden.

Original languageEnglish
Pages (from-to)2409-2413
Number of pages5
JournalAsian Pacific journal of cancer prevention : APJCP
Volume20
Issue number8
DOIs
Publication statusPublished - 01-08-2019

Fingerprint

Early Detection of Cancer
Uterine Cervical Neoplasms
Urine
DNA
Confidence Intervals
DNA-Directed DNA Polymerase
Acetic Acid
Developing Countries
Cross-Sectional Studies
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this

Sabeena, Sasidharanpillai ; Kuriakose, Santhosh ; Binesh, Damodaran ; Abdulmajeed, Jazeel ; Dsouza, Giselle ; Ramachandran, Amrutha ; Vijaykumar, Bindu ; Aswathyraj, Sushama ; Devadiga, Santhosha ; Ravishankar, Nagaraja ; Arunkumar, Govindakarnavar. / The Utility of Urine-Based Sampling for Cervical Cancer Screening in Low-Resource Settings. In: Asian Pacific journal of cancer prevention : APJCP. 2019 ; Vol. 20, No. 8. pp. 2409-2413.
@article{f4116897edb840f5b32b89cad7fb5da2,
title = "The Utility of Urine-Based Sampling for Cervical Cancer Screening in Low-Resource Settings",
abstract = "Background: WHO has recommended Visual Inspection with Acetic acid (VIA) or Human Papillomavirus (HPV) DNA testing if feasible, for cervical cancer screening in low income countries. However, the number of women undergoing screening is very low as a result of limited information, inadequate infrastructure and invasive nature of sampling. Methods: A cross sectional study was carried out comparing HPV DNA detection by Polymerase Chain Reaction (PCR) in paired cervical and urine samples procured from histologically confirmed cervical cancer cases. Results: Amongst the samples collected from 114 cervical cancer cases, HPV DNA was tested positive in cervical samples of 89 (78.1{\%}) and urine samples of 55 (48.2{\%}) patients. The agreement between the two sampling methods was 66.7{\%} and the kappa value was 0.35 indicating a fair agreement. The sensitivity of HPV detection using urine samples was 59.6{\%} (95{\%} confidence interval 49.16{\%}-69.15{\%}) and the specificity was 92{\%} (95{\%} confidence interval 75.0{\%}-97.8{\%}). Conclusion: Even though not acceptable as an HPV DNA screening tool due to low sensitivity, the urine sampling method is inexpensive and more socially acceptable for large epidemiological surveys in developing countries to estimate the burden.",
author = "Sasidharanpillai Sabeena and Santhosh Kuriakose and Damodaran Binesh and Jazeel Abdulmajeed and Giselle Dsouza and Amrutha Ramachandran and Bindu Vijaykumar and Sushama Aswathyraj and Santhosha Devadiga and Nagaraja Ravishankar and Govindakarnavar Arunkumar",
year = "2019",
month = "8",
day = "1",
doi = "10.31557/APJCP.2019.20.8.2409",
language = "English",
volume = "20",
pages = "2409--2413",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "8",

}

Sabeena, S, Kuriakose, S, Binesh, D, Abdulmajeed, J, Dsouza, G, Ramachandran, A, Vijaykumar, B, Aswathyraj, S, Devadiga, S, Ravishankar, N & Arunkumar, G 2019, 'The Utility of Urine-Based Sampling for Cervical Cancer Screening in Low-Resource Settings', Asian Pacific journal of cancer prevention : APJCP, vol. 20, no. 8, pp. 2409-2413. https://doi.org/10.31557/APJCP.2019.20.8.2409

The Utility of Urine-Based Sampling for Cervical Cancer Screening in Low-Resource Settings. / Sabeena, Sasidharanpillai; Kuriakose, Santhosh; Binesh, Damodaran; Abdulmajeed, Jazeel; Dsouza, Giselle; Ramachandran, Amrutha; Vijaykumar, Bindu; Aswathyraj, Sushama; Devadiga, Santhosha; Ravishankar, Nagaraja; Arunkumar, Govindakarnavar.

In: Asian Pacific journal of cancer prevention : APJCP, Vol. 20, No. 8, 01.08.2019, p. 2409-2413.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The Utility of Urine-Based Sampling for Cervical Cancer Screening in Low-Resource Settings

AU - Sabeena, Sasidharanpillai

AU - Kuriakose, Santhosh

AU - Binesh, Damodaran

AU - Abdulmajeed, Jazeel

AU - Dsouza, Giselle

AU - Ramachandran, Amrutha

AU - Vijaykumar, Bindu

AU - Aswathyraj, Sushama

AU - Devadiga, Santhosha

AU - Ravishankar, Nagaraja

AU - Arunkumar, Govindakarnavar

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Background: WHO has recommended Visual Inspection with Acetic acid (VIA) or Human Papillomavirus (HPV) DNA testing if feasible, for cervical cancer screening in low income countries. However, the number of women undergoing screening is very low as a result of limited information, inadequate infrastructure and invasive nature of sampling. Methods: A cross sectional study was carried out comparing HPV DNA detection by Polymerase Chain Reaction (PCR) in paired cervical and urine samples procured from histologically confirmed cervical cancer cases. Results: Amongst the samples collected from 114 cervical cancer cases, HPV DNA was tested positive in cervical samples of 89 (78.1%) and urine samples of 55 (48.2%) patients. The agreement between the two sampling methods was 66.7% and the kappa value was 0.35 indicating a fair agreement. The sensitivity of HPV detection using urine samples was 59.6% (95% confidence interval 49.16%-69.15%) and the specificity was 92% (95% confidence interval 75.0%-97.8%). Conclusion: Even though not acceptable as an HPV DNA screening tool due to low sensitivity, the urine sampling method is inexpensive and more socially acceptable for large epidemiological surveys in developing countries to estimate the burden.

AB - Background: WHO has recommended Visual Inspection with Acetic acid (VIA) or Human Papillomavirus (HPV) DNA testing if feasible, for cervical cancer screening in low income countries. However, the number of women undergoing screening is very low as a result of limited information, inadequate infrastructure and invasive nature of sampling. Methods: A cross sectional study was carried out comparing HPV DNA detection by Polymerase Chain Reaction (PCR) in paired cervical and urine samples procured from histologically confirmed cervical cancer cases. Results: Amongst the samples collected from 114 cervical cancer cases, HPV DNA was tested positive in cervical samples of 89 (78.1%) and urine samples of 55 (48.2%) patients. The agreement between the two sampling methods was 66.7% and the kappa value was 0.35 indicating a fair agreement. The sensitivity of HPV detection using urine samples was 59.6% (95% confidence interval 49.16%-69.15%) and the specificity was 92% (95% confidence interval 75.0%-97.8%). Conclusion: Even though not acceptable as an HPV DNA screening tool due to low sensitivity, the urine sampling method is inexpensive and more socially acceptable for large epidemiological surveys in developing countries to estimate the burden.

UR - http://www.scopus.com/inward/record.url?scp=85071737771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071737771&partnerID=8YFLogxK

U2 - 10.31557/APJCP.2019.20.8.2409

DO - 10.31557/APJCP.2019.20.8.2409

M3 - Article

VL - 20

SP - 2409

EP - 2413

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 8

ER -